MEDICAL THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA

[1] ADELSTEIN SJ, 1987, NUCL MED BIOL, V14, P165

[2] ALLWEISS P, 1984, J NUCL MED, V25, P755

[3] AMINO N, 1975, CANCER, V36, P963, DOI 10.1002/1097-0142(197509)36:3<963::AID-CNCR2820360319>3.0.CO

[4] 2-3

[5] FRACTIONATED DOSES OF RADIOIODINE FOR ABLATION OF POSTSURGICAL THYROID-TISSUE REMNANTS [J]. CLINICAL NUCLEAR MEDICINE, 1990, 15 (10) : 676 - 677

[6] ARNSTEIN NB, 1986, J NUCL MED, V27, P1764

[7] THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) : 806 - 814

[8] HYPOTHYROIDISM AFTER TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (24) : 1557 - 1563

[9] IMMUNOLOGICAL ASPECTS OF CANCERS ARISING FROM THYROID FOLLICULAR CELLS [J]. ENDOCRINE REVIEWS, 1993, 14 (06) : 729 - 746

[10] BALME HW, 1954, LANCET, V1, P812

[1] ADELSTEIN SJ, 1987, NUCL MED BIOL, V14, P165

[2] ALLWEISS P, 1984, J NUCL MED, V25, P755

[3] AMINO N, 1975, CANCER, V36, P963, DOI 10.1002/1097-0142(197509)36:3<963::AID-CNCR2820360319>3.0.CO

[4] 2-3

[5] FRACTIONATED DOSES OF RADIOIODINE FOR ABLATION OF POSTSURGICAL THYROID-TISSUE REMNANTS [J]. CLINICAL NUCLEAR MEDICINE, 1990, 15 (10) : 676 - 677

[6] ARNSTEIN NB, 1986, J NUCL MED, V27, P1764

[7] THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) : 806 - 814

[8] HYPOTHYROIDISM AFTER TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (24) : 1557 - 1563

[9] IMMUNOLOGICAL ASPECTS OF CANCERS ARISING FROM THYROID FOLLICULAR CELLS [J]. ENDOCRINE REVIEWS, 1993, 14 (06) : 729 - 746

[10] BALME HW, 1954, LANCET, V1, P812